The World Health Organization (WHO) estimates that nearly 630 million years of healthy life were lost in 2015 due to the...
Queen’s University Belfast and Domainex are pleased to announce that their joint project team has successfull...
Wareham Development announced that it has executed a lease for 78,000 square feet over several floors of the newly-const...
Gilead Sciences, Inc. has announced HepConnect, a five-year, multi-million dollar initiative aimed at addressing the sha...
Novartis has received the US Food and Drug Administration (FDA) approval of Mayzent® (siponimod) for the treatm...
Eli Lilly and Company and ImmuNext, Inc. have announced a global licensing and research collaboration focused on the stu...
Researchers have found multiple applications for the CRISPR (Clustered Regularly Interspersed Short Palindromic Repeats)...
Swedish digital health start-up Pilloxa has entered a strategic collaboration with Bayer AB. Pilloxa helps patients ta...
Impulse Dynamics, developer of the implantable Optimizer® Smart System for delivering CCM™ therapy, annou...
Dentavax, developed by Muno-Vax Biotechnologies, gives your oral mucosa's immune system a boost to minimize gingivitis, ...
Ascendis Pharma A/S, a biopharmaceutical company that utilizes its innovative TransCon technology to address unmet medic...
Thermo Fisher Scientific Inc., the world leader in serving science, and Brammer Bio, a leader in viral vector manufactur...
Inovio Pharmaceuticals has announced that its Ebola vaccine, INO-4201, was safe, tolerable, and generated strong T cell ...
ALZPROTECT, a biopharmaceutical company engaged in the development of drugs for the treatment of Alzheimer's disease, an...
Jazz Pharmaceuticals plc has announced that the U.S. Food and Drug Administration (FDA) approved Sunosi (solriamfetol) t...
Royal Philips, a global leader in health technology, recently announced that the company has received 22 prestigious awa...
BioInvent International AB, focused on the discovery and development of novel and first-in-class immuno-regulatory antib...
WHO has issued new guidance to improve treatment of multidrug resistant TB (MDR-TB). WHO is recommending shift...
